Quick Answer
Apogee Therapeutics, Inc. reported Shares Outstanding of 68.40 million shares for fiscal year 2025.
Apogee Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 68.40M | +17.8% |
| 2024 | 58.06M | +20.1% |
| 2023 | 48.34M | — |
| 2022 | 0 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 59.32M | +4.2% | +1.3% |
| June 30, 2025 | 58.56M | +3.3% | +0.4% |
| March 31, 2025 | 58.30M | +3.4% | +0.4% |
| December 31, 2024 | 58.06M | +20.1% | +2.0% |
| September 30, 2024 | 56.90M | +18.5% | +0.4% |
| June 30, 2024 | 56.68M | — | +0.5% |
| March 31, 2024 | 56.37M | — | +16.6% |
| December 31, 2023 | 48.34M | — | +0.7% |
- Apogee Therapeutics, Inc. showed an increase of +17.8% in Shares Outstanding compared to the prior fiscal year.
- The most recent figure is from Apogee Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: